InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.62%
)
US TECH 100
19,468.40
(
0.99%
)
Dow Jones
39,331.85
(
0.41%
)
Brent Oil
86.38
(
-0.17%
)
Bitcoin
61,943.94
(
-1.44%
)
Post# of 252465
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: Whalatane post# 210684

Tuesday, 04/18/2017 1:26:39 PM

Tuesday, April 18, 2017 1:26:39 PM

Post# of 252465
GLPG:

I'll be interested to see how filgotinib fares. I think it has a bit of an advantage on the hemoglobin issue.

Otherwise, I don't think there is any clarity on its AE profile being safer. Lipids, creatinine etc... appear to overlap with baricitinib.

But in any case, it definitely has taken a huge leap towards catching up and possibly overtaking baricitinib.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up